anmelden
SPI
18.574,54
PKT
-62,04
PKT
-0,33
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.12.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 16.12.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 15.12.14 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.12.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 12.12.14 | UBS buy | Kepler Cheuvreux | |
| 12.12.14 | Novartis buy | UBS AG | |
| 11.12.14 | Roche buy | UBS AG | |
| 11.12.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 10.12.14 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.12.14 | Roche overweight | JP Morgan Chase & Co. | |
| 10.12.14 | Zurich Insurance neutral | JP Morgan Chase & Co. | |
| 10.12.14 | Holcim Neutral | Merrill Lynch & Co., Inc. | |
| 10.12.14 | Holcim Underperform | Merrill Lynch & Co., Inc. | |
| 10.12.14 | UBS buy | Deutsche Bank AG | |
| 10.12.14 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 09.12.14 | Givaudan buy | Kepler Cheuvreux | |
| 09.12.14 | Roche buy | Merrill Lynch & Co., Inc. | |
| 09.12.14 | Novartis Neutral | Merrill Lynch & Co., Inc. | |
| 09.12.14 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 09.12.14 | Zurich Insurance Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.12.14 | Zurich Insurance Equal weight | Barclays Capital | |
| 09.12.14 | Swiss Re Equal weight | Barclays Capital | |
| 09.12.14 | Novartis Neutral | Merrill Lynch & Co., Inc. | |
| 09.12.14 | ABB (Asea Brown Boveri) Equal weight | Barclays Capital | |
| 08.12.14 | UBS buy | Goldman Sachs Group Inc. | |
| 08.12.14 | UBS buy | Goldman Sachs Group Inc. | |
| 08.12.14 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 05.12.14 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 05.12.14 | Givaudan Neutral | HSBC | |
| 05.12.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 05.12.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 03.12.14 | BB Biotech Verkaufen | Independent Research GmbH | |
| 03.12.14 | Roche overweight | Morgan Stanley | |
| 03.12.14 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 03.12.14 | Novartis Equal-Weight | Morgan Stanley | |
| 03.12.14 | Nestlé Sell | Goldman Sachs Group Inc. | |
| 02.12.14 | UBS buy | Citigroup Corp. | |
| 01.12.14 | Givaudan buy | Deutsche Bank AG | |
| 28.11.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 28.11.14 | Swiss Re market-perform | Bernstein Research |